Latest Tissue plasminogen activator Stories
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke.
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI).
Researchers from the Duke Clinical Research Institute have ruled the clot-busting drug tPA (tissue plasminogen activator) safe for acute stroke patients on the home blood thinner warfarin.
Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients.
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA).
Cut your toe, and platelets -- those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.
The mantra in stroke care is “time is brain.”
Pulmonary embolism -- the sudden blockage of an artery in the lung -- is estimated to cause over 100,000 deaths each year in the U.S.